{"DataElement":{"publicId":"7430985","version":"1","preferredName":"Prior Investigational Therapeutic Procedure Half Life Count","preferredDefinition":"The numerical quantity related to half-lives of prior investigational therapy.","longName":"7425509v1.0:2018392v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"7425509","version":"1","preferredName":"Prior Investigational Therapeutic Procedure Half Life","preferredDefinition":"Earlier in time or order._In the process of being studied; experimental._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The amount of time needed for a material to lose half of its physical, chemical, or biological activity.","longName":"3440626v1.0:2939206v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"3440626","version":"1","preferredName":"Prior Investigational Therapeutic Procedure","preferredDefinition":"Earlier in time or order.:In the process of being studied; experimental.  (NCI):An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25629:C28041:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Investigational","conceptCode":"C28041","definition":"In the process of being studied; experimental.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE222540-1323-83B9-E040-BB89AD435B86","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2939206","version":"1","preferredName":"Half Life","preferredDefinition":"The time it takes for a substance to lose half of its pharmacologic, physiologic, or radiologic activity.","longName":"C70916","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Half Life","conceptCode":"C70916","definition":"The amount of time needed for a material to lose half of its physical, chemical, or biological activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7328A7B3-AD20-CA84-E040-BB89AD435FBD","latestVersionIndicator":"Yes","beginDate":"2009-09-09","endDate":null,"createdBy":"UMLLOADER_CABIOPRD","dateCreated":"2009-09-09","modifiedBy":"ONEDATA","dateModified":"2009-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF843127-3CD3-58D9-E053-4EBD850AA7D2","latestVersionIndicator":"Yes","beginDate":"2020-09-17","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-09-17","modifiedBy":"MORENOC","dateModified":"2021-03-01","changeDescription":"3/1/2021: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018392","version":"1","preferredName":"Count","preferredDefinition":"The quantity of the specified item.","longName":"CT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261845","version":"1","preferredName":"Count","preferredDefinition":"To determine the number or amount of something; the result of this activity.","longName":"C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-646B-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-13","modifiedBy":"ONEDATA","dateModified":"2005-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B3BF4389-4489-5F2C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-08","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/11/17 tt transferred context, added reg status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"QVAL_PRITXHLF","type":"OID, Alliance","context":"Alliance"}],"ReferenceDocuments":[{"name":"Number of half-lives of Prior","type":"Preferred Question Text","description":"Number of half-lives of Prior Investigational Therapy","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFF9D7CF-6440-32F3-E053-4EBD850A865C","latestVersionIndicator":"Yes","beginDate":"2020-09-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-09-23","modifiedBy":"MORENOC","dateModified":"2021-03-02","changeDescription":"3/1/2021: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}